Valdecoxib
CAS No. 181695-72-7
Valdecoxib ( Bextra )
Catalog No. M12790 CAS No. 181695-72-7
Valdecoxib was removed from the Canadian, U.S., and E.U. markets in 2005 due to concerns about possible increased risk of heart attack and stroke.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 53 | In Stock |
|
10MG | 81 | In Stock |
|
25MG | 176 | In Stock |
|
50MG | 324 | In Stock |
|
100MG | 482 | In Stock |
|
500MG | 1071 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameValdecoxib
-
NoteResearch use only, not for human use.
-
Brief DescriptionValdecoxib was removed from the Canadian, U.S., and E.U. markets in 2005 due to concerns about possible increased risk of heart attack and stroke.
-
DescriptionValdecoxib was removed from the Canadian, U.S., and E.U. markets in 2005 due to concerns about possible increased risk of heart attack and stroke.
-
SynonymsBextra
-
PathwayChromatin/Epigenetic
-
TargetCOX
-
RecptorCOX-2
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number181695-72-7
-
Formula Weight314.36
-
Molecular FormulaC16H14N2O3S
-
Purity>98%(HPLC)
-
SolubilityEthanol: 18 mg/mL (57.25 mM); DMSO: 63 mg/mL (200.4 mM)
-
SMILESCC1=C(C2=CC=C(S(N)(=O)=O)C=C2)C(C3=CC=CC=C3)=NO1
-
Chemical Name4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Talley JJ, et al. J Med Chem. 2000 Mar 9;43(5):775-7.
molnova catalog
related products
-
COX-2-IN-1
COX-2-IN-1 is a potent and selective COX-2 inhibitor (IC50: 3.9 μM).
-
Tilmacoxib
Tilmacoxib (JTE-522) is a potent, selective inhibitor of cyclooxygenase-2 (COX-2) that inhibits human recombinant COX-2 with IC50 of 85 nM.
-
Metyrosine
Metyrosine is an antihypertensive drug and could be used as a tyrosine hydroxylase inhibitor.Metyrosine significantly inhibits high COX-2 activity.?Metyrosine is a very effective agent for blood pressure control.